CD68 and non-small cell lung carcinoma: However, it is worth noting that patients with elevated SHP-2 expression in total TAMs exhibited a poorer prognosis, suggesting that CD68+SHP2+ TAMs could serve as a promising prognostic marker in NSCLC.